1. Home
  2. SPXC vs RGEN Comparison

SPXC vs RGEN Comparison

Compare SPXC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPXC
  • RGEN
  • Stock Information
  • Founded
  • SPXC 1912
  • RGEN 1981
  • Country
  • SPXC United States
  • RGEN United States
  • Employees
  • SPXC N/A
  • RGEN N/A
  • Industry
  • SPXC Industrial Machinery/Components
  • RGEN Medical/Dental Instruments
  • Sector
  • SPXC Industrials
  • RGEN Health Care
  • Exchange
  • SPXC Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • SPXC 9.1B
  • RGEN 8.2B
  • IPO Year
  • SPXC N/A
  • RGEN N/A
  • Fundamental
  • Price
  • SPXC $226.82
  • RGEN $146.68
  • Analyst Decision
  • SPXC Buy
  • RGEN Buy
  • Analyst Count
  • SPXC 8
  • RGEN 11
  • Target Price
  • SPXC $209.00
  • RGEN $170.90
  • AVG Volume (30 Days)
  • SPXC 407.8K
  • RGEN 1.0M
  • Earning Date
  • SPXC 10-30-2025
  • RGEN 10-28-2025
  • Dividend Yield
  • SPXC N/A
  • RGEN N/A
  • EPS Growth
  • SPXC 26.00
  • RGEN N/A
  • EPS
  • SPXC 4.69
  • RGEN 0.03
  • Revenue
  • SPXC $2,161,500,000.00
  • RGEN $707,890,000.00
  • Revenue This Year
  • SPXC $16.08
  • RGEN $17.50
  • Revenue Next Year
  • SPXC $7.86
  • RGEN $12.74
  • P/E Ratio
  • SPXC $48.00
  • RGEN $5,747.86
  • Revenue Growth
  • SPXC 12.60
  • RGEN 11.74
  • 52 Week Low
  • SPXC $115.00
  • RGEN $102.97
  • 52 Week High
  • SPXC $233.71
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • SPXC 71.57
  • RGEN 49.79
  • Support Level
  • SPXC $212.90
  • RGEN $139.40
  • Resistance Level
  • SPXC $224.71
  • RGEN $151.25
  • Average True Range (ATR)
  • SPXC 8.32
  • RGEN 6.85
  • MACD
  • SPXC 2.83
  • RGEN -2.13
  • Stochastic Oscillator
  • SPXC 85.15
  • RGEN 24.34

About SPXC SPX Technologies Inc.

SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: